Tag: Cancer

Study finds a weak handshake may predict an early death

What does YOUR handshake reveal? Study finds a weaker grip is linked to an early death from cancer, lung disease, or a heart attack Scientists measured the grip strength of half a million people over three years They compared their grip with their health outcomes over time The weaker the grip, they found, the higher

Immune cell provides cradle for mammary stem cells: Study shows how macrophages and mammary stem cells talk to each other through chemical signaling.

A new study finds that one of the toughest characters in the immune system, the macrophage, has a nurturing side, at least when it comes to guarding the developing breast. The study published online this week in the journal Science found that macrophages play an important role in maintaining the mammary gland’s stem cell niche,

Scientists uncover a new face of a famous protein, SWI2/SNF2 ATPase

A team of Texas A&M and Texas A&M AgriLife Research scientists now have a deeper understanding of a large switch/sucrose non-fermentable (SWI/SNF) protein complex that plays a pivotal role in plant and human gene expression that causes life-threatening diseases such as cancer. Their findings could lead to more targeted therapies and help with physiological improvements

My cancer is in remission – does this mean I’m cured?

So you’ve been through cancer treatment and your doctor has called you in for “some good news”. Satisfied, she tells you your cancer is “in remission.” What does this mean? Are you cured? Is the cancer gone forever? And what about all those stories you’ve heard of someone who thought they’d “won the battle” –

Acupuncture and cognitive behavioral therapy for treating insomnia in cancer survivors

A Patient-Centered Outcomes Research Institute (PCORI)-supported randomized clinical trial of cancer survivors showed that eight weeks of either acupuncture or cognitive behavioral therapy for insomnia (CBT-I) decreased the severity of insomnia among cancer survivors, though improvements were greatest among patients receiving cognitive behavioral therapy. The study will be presented at the upcoming 2018 ASCO Annual

Treating muscle wasting improved cancer survival

Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer model without affecting the tumour size. This effect was not found when the mice were treated with the recombinant protein

This girl’s family desperately need a blood door

Bruises on a five-year-old girl’s legs that have turned into a race against time to beat cancer: She has 2 months to find a stem cell donor but her parents fear they won’t because she is Asian Kaiya Patel, five, has a rare and aggressive form of leukaemia Unexplained bruises appeared on Kaiya’s legs but

Large gender imbalance in funding given for cancer research

Male researchers receive far greater funding for cancer research than their female equivalents, suggests a study published in the journal BMJ Open. Within the European Union (EU), women represent nearly half of the workforce and more than half of all university graduates, but they are under-represented in senior positions in the workplace. In science, research

Researchers make key discovery about human cancer virus protein

University of Minnesota researchers in the dentistry school-based Institute for Molecular Virology (IMV) have made a key discovery that could have important implications for developing a strategy to stop the spread of a highly infectious virus currently spreading among remote areas of central Australia. Called human T-cell leukemia virus type 1 (HTLV-1), infection rates are

Study paves the way for better treatment of prostate cancer

A new study published today has found a way to identify men with locally advanced prostate cancer who are less likely to respond well to radiotherapy. Led by Professor Catharine West, The University of Manchester team created a method of selecting prostate cancer patients who would benefit from treatments which target oxygen deficient tumours. The